HPLC Fraction Collection Storage System
Porvair Sciences has announced a complete storage solution for HPLC fractions comprising its 2 mL round deep well microplate and high integrity cap mat seals.
The revolutionary design of the 2 mL deep well plate, which for the first time provides scientists with a genuine 2 mL working volume in a 45 mm height plate, is now coupled with a choice of specially designed cap mats. These flexible, re-usable cap mats prevent evaporation and allow transport and storage of samples in the 2 mL plate without the need for expensive heat seals or leaky adhesive-based seals.
To ensure complete confidence in the integrity of your sealed HPLC autosampler or fraction collector samples, Porvair has included it’s popular, flexible pre-scored silicone cap mats with double O-ring in the package.
For a limited period Porvair Sciences is offering a free pack of 50 cap mats with each order for two or more cases of 50 x 2 mL round well plates, creating a valuable saving for your lab. This offer runs until 30 November 2014 and applies to sales of these products in the European Union only, either via authorised Porvair Distributors or direct from Porvair Sciences at www.microplates.com. Shipping charges and local taxes may apply.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance